FMP
ImmunoCellular Therapeutics, Ltd.
IMUC
PNK
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. Immunocellular Therapeutics, Ltd. was founded in 2020 and is headquartered in Montvale, New Jersey.
0.158 USD
0.0564 (35.7%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Dr. Irach B. Taraporewala B.S., M.S., Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.eompharma.comexchange
PNK
Description
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. Immunocellular Therapeutics, Ltd. was founded in 2020 and is headquartered in Montvale, New ...
CIK
0000822411
ISIN
US4525364026
CUSIP
452536204
Address
136 Summit Avenue
Phone
201-351-0605
Country
US
Employee
3
IPO Date
Jan 8, 2021
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
IMUC Financial Summary
CIK
0000822411
Exchange
PNK
Industry
Biotechnology
Sector
Healthcare
CUSIP
452536204
ISIN
US4525364026
Country
US
Price
0.16
Beta
0.89
Volume Avg.
2.73k
Market Cap
17.9M
Shares
-
52-Week
0.012-0.3
DCF
-0.04
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
0.02
P/B
-
Website
https://www.eompharma.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest IMUC News
It looks like there's no news available.
